Status:
COMPLETED
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
Lead Sponsor:
In His Image
Collaborating Sponsors:
Kos Pharmaceuticals
Conditions:
Hyperlipidemia
Mixed Hyperlipidemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate the benefits of combination niacin ER/lovastatin in patients receiving standard care who are not at LDL goal per ATP III guidelines.
Detailed Description
Both LDL and HDL are important contributors in the pathophysiology of atherosclerosis and coronary artery disease (CAD); however, HDL is often ignored in primary care. The combination of niacin extend...
Eligibility Criteria
Inclusion
- \>18 years old with CAD or risk factors for CAD
- under standard care at Family Medical Care of Tulsa
- not at LDL goal per ATP III guidelines
Exclusion
- pregnancy/lactating
- liver disease
- allergies to statin or niacin
- active peptic ulcer disease
- previous treatment with combination therapy for dyslipidemia
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2004
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00345657
Start Date
July 1 2003
End Date
May 1 2004
Last Update
June 28 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Family Medical Care of Tulsa
Tulsa, Oklahoma, United States, 74136